The KidGen National Kidney Genomic Program is an Australian national and translational genomics program addressing the clinical need to urgently improve identification and diagnosis of novel monogenic rare kidney diseases. It seeks to improve the diagnostic and clinical outcomes of Australian patients and families affected by genetic kidney disease (GKD) through the personalised application of novel genomic approaches at national scale and within a multidisciplinary context.
The program will increase the genetic diagnosis rate in this space towards 70 per cent by 2025 while enabling earlier and more efficient genomic diagnosis of rare kidney disorders. World-leading genomic approaches will be utilised to improve connection and capacity, including the application of advanced research and functional genomics to identify and validate novel gene variants in an extensive patient cohort. Through an established national network of multidisciplinary clinics this will inform clinical options and pathways for affected Australian families and accelerate translation and integration of genomics knowledge and technology into kidney clinical practice.
Professor Andrew Mallett
Townsville Institute of Health Research and Innovation